Filip Scheperjans

Filip Scheperjans serves as Adjunct Professor of Neurology at the University of Helsinki's Faculty of Medicine and Supervisor for the Doctoral Programme in Clinical Research at HUS Neurocenter. His academic appointment commenced on June 24, 2020, and he maintains active clinical and research roles within Helsinki University Hospital's neurology division.

Professor Scheperjans' research centers on Parkinson's disease pathophysiology with distinctive focus on gut-brain axis mechanisms, particularly gut microbiome interactions. His work investigates REM sleep behavior disorder as an early biomarker, dopaminergic imaging patterns, and complications of advanced Parkinson's therapies. Recent publications reveal growing emphasis on microbial metagenomics and translational clinical applications.

His publication record demonstrates significant expansion from 1 paper in 2002 to 7+ annually since 2021, with 82 total publications including high-impact journals like Scientific Reports and NPJ Parkinson's Disease. Current research output focuses on gut microbiome transplantation trials, dopaminergic imaging correlations, and therapy-related neuropathies.

Professor Scheperjans actively supervises doctoral candidates through the Clinical Research Programme and participates in SPARK Finland's health tech acceleration initiative. His clinical trial on fecal microbiome transplantation for Parkinson's patients has generated substantial media coverage and represents a pioneering therapeutic approach.